Redsense Medical Financials
| REDS Stock | SEK 6.84 0.16 2.29% |
Redsense |
Understanding current and past Redsense Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Redsense Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Redsense Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Redsense Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Redsense Medical AB. Check Redsense Medical's Beneish M Score to see the likelihood of Redsense Medical's management manipulating its earnings.
Redsense Medical Stock Summary
Redsense Medical competes with Genovis AB, Vestum AB, and Karolinska Development. Redsense Medical AB provides blood loss detection devices primarily in Europe and the United States. Redsense Medical AB was founded in 2000 and is headquartered in Halmstad, Sweden. Redsense Medical is traded on Stockholm Stock Exchange in Sweden.| Foreign Associate | UK |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0006965158 |
| Business Address | Gyllenhammarsvg 26 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.redsensemedical.com |
| Phone | 46 35 10 60 30 |
| Currency | SEK - Swedish Kronor |
You should never invest in Redsense Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Redsense Stock, because this is throwing your money away. Analyzing the key information contained in Redsense Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Redsense Medical Key Financial Ratios
Redsense Medical's financial ratios allow both analysts and investors to convert raw data from Redsense Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Redsense Medical over time and compare it to other companies across industries.| Beta | 1.25 | |||
| Z Score | 24.0 |
Redsense Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Redsense Medical's current stock value. Our valuation model uses many indicators to compare Redsense Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Redsense Medical competition to find correlations between indicators driving Redsense Medical's intrinsic value. More Info.Redsense Medical AB is currently regarded as top stock in price to earning category among its peers. It also is currently regarded as top stock in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Redsense Medical's earnings, one of the primary drivers of an investment's value.Redsense Medical Systematic Risk
Redsense Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Redsense Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Redsense Medical correlated with the market. If Beta is less than 0 Redsense Medical generally moves in the opposite direction as compared to the market. If Redsense Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Redsense Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Redsense Medical is generally in the same direction as the market. If Beta > 1 Redsense Medical moves generally in the same direction as, but more than the movement of the benchmark.
Redsense Medical Thematic Clasifications
Redsense Medical AB is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Redsense Medical November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Redsense Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Redsense Medical AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Redsense Medical AB based on widely used predictive technical indicators. In general, we focus on analyzing Redsense Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Redsense Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.87 | |||
| Information Ratio | 0.0031 | |||
| Maximum Drawdown | 22.78 | |||
| Value At Risk | (6.59) | |||
| Potential Upside | 7.69 |
Additional Tools for Redsense Stock Analysis
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.